<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This study evaluates changes in genetic loci of <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid disorders using loss of heterozygosity (LOH) techniques </plain></SENT>
<SENT sid="1" pm="."><plain>We present the combined results of three experiments </plain></SENT>
<SENT sid="2" pm="."><plain>First, examination of a panel of genetic loci in groups of <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> was evaluated </plain></SENT>
<SENT sid="3" pm="."><plain>The second experiment involved microdissection of megakaryocytes from <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> and comparison of their genetic changes to surrounding neoplastic marrow elements </plain></SENT>
<SENT sid="4" pm="."><plain>Finally, we compared results of LOH studies of <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> to those of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 41 bone marrow biopsies were evaluated </plain></SENT>
<SENT sid="6" pm="."><plain>Twenty-seven were <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (11 <z:hpo ids='HP_0011010'>chronic</z:hpo> idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo>, 11 essential <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemia</z:e>, 5 <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera) </plain></SENT>
<SENT sid="7" pm="."><plain>The remaining cases consisted of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (total=5; <z:e sem="disease" ids="C1318550" disease_type="Neoplastic Process" abbrv="">RAEB-1</z:e>=2; <z:e sem="disease" ids="C1318551" disease_type="Neoplastic Process" abbrv="">RAEB-2</z:e>=2; <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, not otherwise specified=1) and <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (n=8) </plain></SENT>
<SENT sid="8" pm="."><plain>The abnormalities in <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> were distributed as follows: D7S2554-4/14 (5/14); D8S263-4/15 (5/15); D9S157-5/15 (5/15); D9S161-7/17 (6/17); D13S319-5/14 (4/14); TP53-5/16 (5/16); D20S108-4/15 (4/15) </plain></SENT>
<SENT sid="9" pm="."><plain>In 75% cases diagnosed as <z:e sem="disease" ids="C0040028" disease_type="Disease or Syndrome" abbrv="">essential thrombocythemia</z:e> (6/8), both cases of <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (2/2), and 29% cases of <z:hpo ids='HP_0011010'>chronic</z:hpo> idiopathic <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> (2/7), there were genetic differences between the megakaryocytes and the surrounding marrow </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that in some cases, megakaryocytes have different clonal abnormalities than surrounding hematopoietic tissue </plain></SENT>
<SENT sid="11" pm="."><plain>The genetic profiles of <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> had several differences from those of <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Although different from both, <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> appeared more similar to <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> using these techniques </plain></SENT>
</text></document>